Trial Profile
Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia
- Focus Pharmacodynamics
- 08 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 20 Sep 2010 New trial record